Costs in general practiceBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7065.1143b (Published 02 November 1996) Cite this as: BMJ 1996;313:1143
- Michael Robertson
- General practitioner Marcham Road Family Health Centre, Abingdon, Oxfordshire OX14 1BT
EDITOR,—P D P Pharoah and W Hollingworth have calculated the potential costs and benefits of the increased use of statins to prevent deaths from coronary heart disease in a health authority.1 A similar and simpler calculation can be done for the patients of a British general practice.
The results of the west of Scotland coronary prevention study of pravastatin treatment in men with raised cholesterol concentration showed a headline reduction of 32% in cardiovascular mortality and 22% in all cause mortality after …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial